Literature DB >> 6859785

A proposed new method for the treatment of dry mouth.

N J Marks, B J Roberts.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6859785      PMCID: PMC2494288     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


× No keyword cloud information.
  8 in total

1.  [Therapy of mouth and pharynx dryness following radiotherapy].

Authors:  C H Håkansson; T R Möller; G Wollmark
Journal:  Strahlentherapie       Date:  1973-08

2.  [Sjogren's syndrome and its therapy. A therapeutic attempt using antilymphocyte serum].

Authors:  K W Albegger; G P Tilz
Journal:  Z Laryngol Rhinol Otol       Date:  1972-07

3.  [Synthetic saliva in the treatment of hyposialies, especially in radiation sialadenitis].

Authors:  J Matzker; J Schreiber
Journal:  Z Laryngol Rhinol Otol       Date:  1972-07

4.  Sputum viscoelasticity. I. A new methodology.

Authors:  B Barnett; M J Dulfano
Journal:  Am Rev Respir Dis       Date:  1970-05

5.  Experimental toxicity of a high molecular weight poly(ethylene oxide).

Authors:  H F Smyth; C S Weil; M D Woodside; J B Knaak; L J Sullivan; C P Carpenter
Journal:  Toxicol Appl Pharmacol       Date:  1970-03       Impact factor: 4.219

6.  The management of radiation caries.

Authors:  F Coffin
Journal:  Br J Oral Surg       Date:  1973-07

7.  The effect of mucin-containing artificial saliva on severe xerostomia.

Authors:  E J 'S-Gravenmade; P A Roukema; A K Panders
Journal:  Int J Oral Surg       Date:  1974

8.  Treatment of xerostomia: a double-blind trial in 108 patients with Sjögren's syndrome.

Authors:  A C Klestov; J Webb; D Latt; G Schiller; K McNamara; D Y Young; J Hobbes; J Fetherston
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1981-06
  8 in total
  1 in total

Review 1.  Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome.

Authors:  W A van der Reijden; A Vissink; E C Veerman; A V Amerongen
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.